LTC Properties Inc vs 10X Genomics Inc — how do they compare? LTC Properties Inc trades at $41.74 (market cap $2.15B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is far larger — about 2.5× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.44% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| LTC | TXG | |
|---|---|---|
Market Cap | $2.15B | $5.48B |
Sector | Real Estate | Health |
52-Week High | $41.92 | $45.80 |
52-Week Low | $33.98 | $11.34 |
Enterprise Value | $2.99B | $5.02B |
Dividend Yield | 5.44% | — |
Trailing returns across standard periods
Latest headlines on both assets
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →